{"id":"https://openalex.org/W2900749656","doi":"https://doi.org/10.17077/etd.jn9szibf","title":"An integrin-based mechanism for sensitizing melanomas to therapies","display_name":"An integrin-based mechanism for sensitizing melanomas to therapies","publication_year":2015,"publication_date":"2015-05-01","ids":{"openalex":"https://openalex.org/W2900749656","doi":"https://doi.org/10.17077/etd.jn9szibf","mag":"2900749656"},"language":"en","primary_location":{"id":"doi:10.17077/etd.jn9szibf","doi":"https://doi.org/10.17077/etd.jn9szibf","is_oa":false,"landing_page_url":"https://doi.org/10.17077/etd.jn9szibf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"University of Iowa","raw_type":"dissertation"},"volume":null,"type":"dissertation","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://iro.uiowa.edu/view/delivery/01IOWA_INST/12730709380002771/13731042460002771","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101471248","display_name":"Xiaowen Sun","orcid":"https://orcid.org/0000-0002-0485-2177","observed_orcids":["https://orcid.org/0000-0002-0485-2177"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaowen Sun","raw_affiliation_strings":["University of Iowa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047162645","display_name":"Kris A. DeMali","orcid":"https://orcid.org/0000-0003-0906-1371","observed_orcids":["https://orcid.org/0000-0003-0906-1371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kris A. DeMali","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0906-1371","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070049424","display_name":"Frederick E. Domann","orcid":"https://orcid.org/0000-0002-0489-2179","observed_orcids":["https://orcid.org/0000-0002-0489-2179"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederick E. Domann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0489-2179","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026939827","display_name":"John G. Koland","orcid":"https://orcid.org/0000-0002-5028-4297","observed_orcids":["https://orcid.org/0000-0002-5028-4297"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John G. Koland","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5028-4297","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002846184","display_name":"Apollina Goel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Apollina Goel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089777560","display_name":"Mohammed M. Milhem","orcid":"https://orcid.org/0000-0003-4663-6824","observed_orcids":["https://orcid.org/0000-0003-4663-6824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed M. Milhem","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4663-6824","affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101471248"],"corresponding_institution_ids":["https://openalex.org/I126307644"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.5785999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.5785999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.3991999924182892,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8980000019073486},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9079999923706055},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.6759999990463257},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8119999766349792},{"id":"https://openalex.org/keywords/integrins","display_name":"integrins","score":0.9309999942779541},{"id":"https://openalex.org/keywords/kindlin-2","display_name":"Kindlin-2","score":0.8220000267028809},{"id":"https://openalex.org/keywords/beta1-integrin","display_name":"beta1 integrin","score":0.8949999809265137},{"id":"https://openalex.org/keywords/integrin-beta3","display_name":"CD61","score":1.0},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.6819999814033508},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/integrin-antagonists","display_name":"integrin antagonists","score":0.6740000247955322},{"id":"https://openalex.org/keywords/therapeutic-peptides","display_name":"peptide therapeutics","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.781570553779602},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.6907882690429688},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4695988893508911},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40836822986602783},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3934241831302643},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.37485843896865845},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33784371614456177},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24856626987457275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17971095442771912},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.16560891270637512},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.14596322178840637},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06684422492980957}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.17077/etd.jn9szibf","doi":"https://doi.org/10.17077/etd.jn9szibf","is_oa":false,"landing_page_url":"https://doi.org/10.17077/etd.jn9szibf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"University of Iowa","raw_type":"dissertation"},{"id":"pmh:oai:alma.01IOWA_INST:11730709390002771","doi":null,"is_oa":true,"landing_page_url":"https://iro.uiowa.edu/esploro/outputs/doctoral/An-integrin-based-mechanism-for-sensitizing-melanomas/9983777216802771","pdf_url":"https://iro.uiowa.edu/view/delivery/01IOWA_INST/12730709380002771/13731042460002771","source":{"id":"https://openalex.org/S4306401239","display_name":"Iowa Research Online (The University of Iowa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126307644","host_organization_name":"University of Iowa","host_organization_lineage":["https://openalex.org/I126307644"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Doctoral Thesis"},{"id":"pmh:oai:ir.uiowa.edu:etd-8006","doi":null,"is_oa":false,"landing_page_url":"https://ir.uiowa.edu/etd/6506","pdf_url":null,"source":{"id":"https://openalex.org/S4377196317","display_name":"Iowa Research Online (University of Iowa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126827851","host_organization_name":"University of Iowa","host_organization_lineage":["https://openalex.org/I126827851"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Theses and Dissertations","raw_type":"dissertation"}],"best_oa_location":{"id":"pmh:oai:alma.01IOWA_INST:11730709390002771","doi":null,"is_oa":true,"landing_page_url":"https://iro.uiowa.edu/esploro/outputs/doctoral/An-integrin-based-mechanism-for-sensitizing-melanomas/9983777216802771","pdf_url":"https://iro.uiowa.edu/view/delivery/01IOWA_INST/12730709380002771/13731042460002771","source":{"id":"https://openalex.org/S4306401239","display_name":"Iowa Research Online (The University of Iowa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126307644","host_organization_name":"University of Iowa","host_organization_lineage":["https://openalex.org/I126307644"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Doctoral Thesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","display_name":"Zero hunger","score":0.6399999856948853}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2900749656.pdf","grobid_xml":"https://content.openalex.org/works/W2900749656.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2318265226","https://openalex.org/W2318655160","https://openalex.org/W2085083547","https://openalex.org/W91368788","https://openalex.org/W2137148013","https://openalex.org/W2324016190","https://openalex.org/W4400919117","https://openalex.org/W7135247528","https://openalex.org/W4247348366","https://openalex.org/W2106005132"],"abstract_inverted_index":{"Metastatic":[0],"melanoma":[1,128,198,304],"is":[2,40,45,65,247],"unusually":[3],"lethal":[4],"with":[5],"a":[6,26,104],"ten":[7],"year":[8],"survival":[9,36],"rate":[10],"of":[11,96,162,188,224,255],"less":[12],"than":[13],"10%.":[14],"Conventional":[15],"DNA-damaging":[16],"agents":[17,88,296],"produce":[18],"little":[19],"improvement":[20],"in":[21,67,82,131,134,233,250,300,303],"patient":[22],"survival.":[23],"Vemurafenib":[24],"(Zelboraf),":[25],"targeted":[27,144],"therapeutic":[28],"that":[29,43,89,113,193,216,245,267,288,291],"inhibits":[30],"the":[31,70,72,94,118,151,184,222,234],"oncogenic":[32],"BRAF":[33],"demonstrates":[34],"significant":[35],"benefit.":[37],"Unfortunately,":[38],"it":[39],"now":[41],"evident":[42],"there":[44],"both":[46],"intrinsic":[47,205],"and":[48,87,120,133,181,218,261,271,282,294],"acquired":[49],"resistance.":[50],"Consequently,":[51],"new":[52],"strategies":[53],"for":[54,153],"sensitizing":[55],"melanomas":[56,97],"to":[57,63,98,129,143,166,173,179,182,200,207,279,285],"vemurafenib":[58,180,201,286,293],"are":[59,79,156,165,221,230],"needed.":[60],"Melanoma":[61],"resistance":[62,142,178,206,284,302],"therapy":[64],"fueled":[66],"part":[68],"by":[69],"integrins,":[71],"major":[73],"cell":[74,119,185],"surface":[75,186],"adhesion":[76],"receptors":[77],"which":[78],"highly":[80],"over-expressed":[81],"melanoma.":[83],"Both":[84],"integrin":[85,123,239,259,264,273],"antagonists":[86],"engage":[90],"defective":[91],"integrins":[92,115,220],"increase":[93],"sensitivity":[95,175,199,281],"chemotherapy.":[99],"Our":[100,190],"laboratory":[101],"has":[102,139],"identified":[103],"novel":[105],"peptide,":[106],"denoted":[107],"vinculin":[108],"activating":[109],"peptide":[110],"or":[111],"VAP":[112,126,138,169,194],"targets":[114],"from":[116],"within":[117],"brings":[121],"aberrant":[122,269],"function":[124,274],"intact.":[125],"sensitizes":[127],"dacarbazine":[130],"vitro":[132],"vivo.":[135],"The":[136,160,253],"effect":[137],"on":[140],"overcoming":[141],"therapies":[145,229,290],"like":[146],"vemurafenib,":[147],"as":[148,150],"well":[149,158],"mechanism":[152],"its":[154],"effects":[155],"not":[157,195,231],"understood.":[159],"goals":[161],"this":[163,208],"project":[164],"determine":[167],"if":[168],"can":[170,276],"be":[171,277,298],"employed":[172,278],"improve":[174,280],"and/or":[176],"overcome":[177,283],"identify":[183],"target":[187,223],"VAP.":[189],"results":[191],"show":[192],"only":[196],"improves":[197],"but":[202],"also":[203],"decreases":[204,262],"promising":[209],"drug.":[210],"In":[211],"addition,":[212],"we":[213,236],"present":[214],"evidence":[215],"\u03b21":[217,258,270],"\u03b23":[219,263,272],"VAP's":[225],"effects.":[226],"Since":[227],"peptide-based":[228],"stable":[232],"clinic,":[235],"explored":[237],"another":[238],"binding":[240],"partner,":[241],"kindlin-2.":[242],"We":[243],"found":[244],"kindlin-2":[246,256],"over":[248],"expressed":[249],"resistant":[251],"melanomas.":[252],"inhibition":[254],"increases":[257],"activation":[260],"functions.":[265],"Agents":[266],"bring":[268],"intact":[275],"suggesting":[287],"combinatorial":[289],"employ":[292],"integrin-based":[295],"might":[297],"efficacious":[299],"combatting":[301],"patients.":[305]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2018-11-29T00:00:00"}